2026-10-28 · By SEPT AI
*By SEPT AI*
U.S. equities closed modestly higher on Wednesday, October 28, 2026, as investors worked through one of the busiest earnings days of the quarter. Gains were broad but shallow, with the blue-chip Dow Jones Industrial Average leading the advance while megacap technology lagged. The Fear & Greed Index settled at 51, squarely in neutral territory, reflecting a market that is neither euphoric nor fearful as it digests a mixed batch of corporate results.
The SPDR Dow Jones Industrial Average ETF (DIA) closed at $524.68, up 0.33%, after trading between $522.80 and $525.77. The small-cap Russell 2000 proxy (IWM) was close behind, finishing at $281.29 for a gain of 0.34%, having ranged from $279.05 to $281.48. The Invesco QQQ Trust (QQQ) added 0.19% to close at $725.48, recovering from a session low of $720.30 to touch a high of $726.13. The S&P 500 proxy (SPY) was the laggard among the four, eking out a 0.12% gain to close at $772.34, with a trading range of $769.24 to $773.36.
The day's tone was set by a torrent of earnings reports spanning industrials, financials, healthcare, and consumer names. With no major macroeconomic releases to distract, stock-specific catalysts drove the action, producing sharp moves in both directions.
Wednesday's earnings calendar skewed heavily toward financials, industrials, and consumer-facing companies, and the results painted a mixed picture. Financials were generally firm, with WEX, Heritage Insurance, FinWise, and Chain Bridge Bancorp all topping estimates. The insurance space, however, showed cracks: Everest Group missed on both earnings and revenue, and AMSF fell short of consensus.
Homebuilders and housing-adjacent names struggled. Meritage Homes missed on both the top and bottom lines, with adjusted earnings of $1.11 per share against a $1.18 consensus and revenue of $1.168 billion falling well short of the $1.305 billion expected. The miss underscored continued pressure on the housing sector.
Healthcare was a mixed bag. Community Health System slashed its fiscal 2026 guidance, sending a cautionary signal about hospital operator margins, while Adial Pharmaceuticals drew attention after shareholders approved a preferred conversion and a higher share cap — a dilutive move that weighed on sentiment.
The most dramatic move of the session came from JDZG, which collapsed 76.35% to close at $1.49 on volume of more than 2.1 million shares. The scale of the decline pointed to a severe company-specific shock.
On the upside, AIOK surged 59.73% to $28.00 on heavy volume of 17.3 million shares, while FTFT jumped 50.53% to $2.86 on 15 million shares. ROMA climbed 40.28% to $7.00, and MGN rose 39.69% to $3.59.
Biotech and life sciences names were prominent among the gainers. Genmab (GMAB) rallied 28.37% to $57.29 on volume exceeding 29 million shares. Prime Medicine (PRME) advanced 26.42% to $5.36, and Replimune (REPL) gained 24.53% to $16.07. AARD rose 24.38% to $1.50, and KIDS added 23.50% to $30.80.
On the losing side, BCAX dropped 44.04% to $9.72, MWYN fell 33.18% to $1.41, and BRAI slid 27.05% to $3.60 on volume of 44.6 million shares. Inhibrx (INBX) declined 22.49% to $73.29, AIAI lost 22.19% to $1.31, and ORCZ fell 20.71% to $14.51.
Key Earnings
The earnings tape was dominated by beats. WEX reported third-quarter adjusted earnings of $6.13 per share, comfortably above the $5.65 forecast, with revenue of $780.1 million beating the $746.0 million estimate. The company then guided fourth-quarter adjusted EPS to $5.67–$5.87, well above the $5.00 consensus, and sales of $760–$780 million against a $713.7 million estimate.
FedEx lifted its full-year outlook alongside its quarterly results, a bullish signal for the broader logistics and industrial economy. Murphy USA posted quarterly profit of $9.59 per share, topping the $8.45 forecast, with revenue of $6.890 billion exceeding the $6.190 billion estimate.
In technology and communications, Impinj guided fourth-quarter adjusted EPS to $0.55–$0.60 and sales of $104–$107 million, both above estimates. Tenable Holdings raised its fiscal 2026 GAAP EPS outlook to $0.24–$0.26 from a prior $0.06–$0.11 range. Bel Fuse guided fourth-quarter sales to $220–$240 million, above the $198–$205.7 million estimates. Sterling Infrastructure lifted its fiscal 2026 GAAP EPS outlook to $19.16–$19.42 from $17.25–$17.85.
Not every report was well received. Fortinet shares fell following its third-quarter earnings release. Sprouts Farmers Market guided fourth-quarter adjusted EPS to $0.47–$0.51, far below the $1.21 estimate. Boot Barn issued third-quarter guidance below consensus at $3.03–$3.19 per share and $785–$802 million in sales. Aurora Innovation cut its fiscal 2026 sales outlook to $9.0 million from a prior $14–16 million range. KKR Real Estate Finance posted an adjusted loss of $2.64 per share, far wider than the $0.07 loss expected.
Among other reporters, ADP earned $2.82 per share against a $2.77 estimate, Aon posted $3.36 versus $3.30 expected, and Align Technology came in at $2.80 against $2.77. AER was a standout, earning $6.56 per share against a $4.56 consensus.
Filings over recent months show insider buying clustered in several names. Republic Services (RSG) has seen 95 insider buys totaling roughly $1.24 billion, while Taiwan Semiconductor (TSM) has drawn 76 buys. Other names showing consistent insider accumulation include Ecolab (ECL), with four buys worth $2.7 million; Loews (L), with two buys totaling $1.1 million; MercadoLibre (MELI), with three buys worth $1.2 million; and Huntington Bancshares (HBAN), with four buys. These reflect positioning built over recent months rather than any single session's activity.
With the earnings floodgates wide open, Thursday promises more of the same. Investors will be watching for follow-through in the beaten-down housing and insurance names, and for any read-across from FedEx's raised outlook to the broader industrial complex. The neutral Fear & Greed reading suggests the market has room to move in either direction, and with guidance revisions flowing in thick and fast — from Sterling's raise to Sprouts' cut — stock-specific volatility is likely to remain elevated.
Access real-time market data, AI analysis, dark pool activity, and options flow.
Start Free Trial